Virtu Financial LLC Acquires New Holdings in GRAIL, Inc. $GRAL

Key Points

• Virtu Financial LLC invested approximately $271,000 in GRAIL, acquiring 10,600 shares during the first quarter of the year.
• GRAIL reported a quarterly loss of ($3.18) EPS, missing analysts' expectations, with revenue of $35.54 million for the quarter.
• Major shareholder Chun R. Ding sold 339,800 shares of GRAIL stock, resulting in a 9.32% decrease in their stake in the company.

Virtu Financial LLC purchased a new position in GRAIL, Inc. (NASDAQ:GRAL - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 10,600 shares of the company's stock, valued at approximately $271,000.

A number of other large investors have also bought and sold shares of GRAL. Caldwell Sutter Capital Inc. bought a new position in shares of GRAIL in the first quarter valued at $28,000. KBC Group NV lifted its stake in shares of GRAIL by 187.7% in the first quarter. KBC Group NV now owns 1,430 shares of the company's stock valued at $37,000 after buying an additional 933 shares in the last quarter. S.A. Mason LLC lifted its stake in shares of GRAIL by 50.1% in the first quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock valued at $38,000 after buying an additional 500 shares in the last quarter. State of Tennessee Department of Treasury bought a new position in shares of GRAIL in the fourth quarter valued at $28,000. Finally, Sterling Capital Management LLC bought a new position in shares of GRAIL in the fourth quarter valued at $29,000.

Analyst Ratings Changes

Separately, Canaccord Genuity Group raised their price objective on shares of GRAIL from $32.00 to $43.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $31.50.

GRAIL Trading Up 3.0%

Shares of GRAL traded up $0.98 during trading hours on Thursday, reaching $33.15. 620,918 shares of the stock traded hands, compared to its average volume of 887,120. The stock has a fifty day simple moving average of $39.35 and a 200 day simple moving average of $36.32. GRAIL, Inc. has a 52 week low of $12.33 and a 52 week high of $63.99. The company has a market cap of $1.20 billion, a price-to-earnings ratio of -2.53 and a beta of 3.26.

GRAIL (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings results on Tuesday, August 12th. The company reported ($3.18) earnings per share for the quarter, missing analysts' consensus estimates of ($3.14) by ($0.04). GRAIL had a negative net margin of 329.86% and a negative return on equity of 16.64%. The firm had revenue of $35.54 million for the quarter, compared to the consensus estimate of $37.57 million. Analysts predict that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.

Insider Activity at GRAIL

In other GRAIL news, CFO Aaron Freidin sold 8,000 shares of GRAIL stock in a transaction dated Tuesday, July 15th. The shares were sold at an average price of $38.93, for a total value of $311,440.00. Following the sale, the chief financial officer owned 286,020 shares of the company's stock, valued at approximately $11,134,758.60. The trade was a 2.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, President Joshua J. Ofman sold 9,692 shares of GRAIL stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $52.00, for a total transaction of $503,984.00. Following the completion of the sale, the president directly owned 492,076 shares in the company, valued at approximately $25,587,952. This represents a 1.93% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 361,694 shares of company stock valued at $17,780,266 over the last ninety days. Corporate insiders own 1.85% of the company's stock.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.